Molecular Genetics BRCA 1 Deletion / Duplication assay
Test Code: Test indication: Methodology: TAT: Sample type : Sample storage and Transportation : Recommendation: Sample unacceptable criteria:
BRCA 1 Deletion / Duplication assay Suspected Breast and Ovarian cancer patient and at risk family members MLPA Screening technology 3 working days 5 ml EDTA Whole Blood Sample to be stored and transported in 2 to 8 degree temperature Kindly include relavent clinical histroy and indications FFPE Tissue, sample collected in other than EDTA, samples not maintained in above recommeded temperature conditions, Clotted or hemolyzed specimen.
Other assays Available: Real time PCR based EGFR mutation detection (Liquid Biopsy is also performed in Plasma) BCRABL (Major), KRAS, BRAF, JAK2 (Exon 14). NGS based Cancer Hotspot assay covering almost all cancer types (Hotspots – Most frequent mutations) BRCA Plus Inherited Breast and Ovarian cancer panel
94963 98078 85906 01094
Corporate Office & Referral Laboratory, DDRC SRL Towers, Panampilly Nagar, Kochi-682 036 Ph: +91 484 2318222, 2318223 email: info@ddrcsrl.com www.ddrcsrl.com